What is the recommended dosage of Cefeperazone (Cefeperazone) Inj (Intravenous injection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefeperazone Intravenous Dosage

For adults with normal renal and hepatic function, administer cefeperazone 2-4 g intravenously every 12 hours, with doses up to 12 g daily in severe infections. 1, 2

Standard Adult Dosing

  • Typical dose range: 2-4 g IV every 12 hours for most infections 1, 2
  • Severe infections: Up to 12 g daily may be administered in divided doses 2
  • Administration methods: Can be given as rapid IV injection (over 3-5 minutes), short infusion (15-30 minutes), or extended infusion (up to 2 hours) 2

Dosing by Clinical Indication

Multidrug-Resistant Gram-Negative Infections

  • For carbapenem-resistant Pseudomonas aeruginosa (CRPA) susceptible to cefoperazone: 3-4 g IV every 6 hours may be considered 3
  • Treatment duration: 5-10 days for complicated urinary tract infections and intra-abdominal infections; 10-14 days for hospital-acquired pneumonia and bloodstream infections 3

Complicated Intra-Abdominal Infections

  • Standard dosing of 2 g IV every 8-12 hours is appropriate for adults 3
  • Should be combined with metronidazole for anaerobic coverage in intra-abdominal infections 3

Pharmacokinetic Considerations

  • Peak serum levels: 202-375 mcg/mL after 2 g IV dose (varies by infusion duration) 2, 4
  • Half-life: 1.6-2.4 hours in normal subjects 2, 4
  • Protein binding: 90% bound to serum proteins 4
  • Elimination: Primarily biliary excretion (60-70%); only 15-36% excreted renally 2, 4

Dosing in Renal Impairment

No dosage adjustment is required for renal impairment alone, as cefeperazone is primarily eliminated via biliary excretion. 1, 4, 5

  • Serum half-life increases minimally in severe renal failure (mean 6.6 hours vs 2 hours in normal function) 1
  • Standard doses of 2-4 g daily do not lead to drug accumulation even in severe renal failure 1
  • In functionally anephric patients, the half-life extends to approximately 3 hours but remains clinically manageable 6
  • Hemodialysis does not significantly remove cefeperazone, so no supplemental dosing is needed post-dialysis 6

Dosing in Hepatic Impairment

Severe hepatic dysfunction requires dosage reduction due to 2-4 fold increase in half-life. 4, 5

  • In severe biliary obstruction, over 90% of the drug shifts to renal excretion 4
  • Despite prolonged half-life, drug accumulation was not observed with 1 g every 12 hours in hepatic dysfunction 5
  • Major dosage modification is only required with concomitant renal AND hepatic dysfunction 5

Pediatric Dosing

  • Neonates and infants: Specific dosing not well-established in provided guidelines; infectious disease consultation recommended 3
  • Children: 150-300 mg/kg/day IV divided every 6-8 hours for serious infections (maximum 12 g/day) 3

Important Clinical Caveats

  • Cefeperazone achieves exceptionally high biliary concentrations (675-6000 mcg/mL), making it particularly useful for biliary tract infections 4
  • Urine levels exceed 32 mcg/mL for at least 12 hours, providing adequate coverage for urinary tract infections 4
  • The drug is not significantly metabolized, reducing drug-drug interaction concerns 5
  • Combination with sulbactam: When cefoperazone is combined with sulbactam (2 g/1 g formulation), the sulbactam component requires dose adjustment in renal failure, but cefoperazone dosing remains unchanged 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.